Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
argenx
ARGX
|
$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Wynn Resorts
WYNN
$12.6B
| $57.6M | 0.04% |
515,126
+3,085
| +0.6% | +$345K |
|
|
TCN
352
DELISTED
Tricon Residential Inc.
TCN
| $57.5M | 0.04% |
7,426,470
+20,040
| +0.3% | +$155K |
|
353
Roper Technologies
ROP
$55.8B
| $57.5M | 0.04% |
130,461
-157,970
| -55% | -$69.6M |
|
354
Alcon
ALC
$39.6B
| $57.1M | 0.04% |
806,064
+235,269
| +41% | +$16.7M |
|
355
89bio
ETNB
$1.32B
| $57.1M | 0.04% |
3,746,038
+2,726,659
| +267% | +$41.5M |
|
356
Entergy
ETR
$39.2B
| $56.7M | 0.04% |
1,051,672
+155,024
| +17% | +$8.35M |
|
357
Arista Networks
ANET
$180B
| $56.4M | 0.04% |
1,344,896
-80,272
| -6% | -$3.37M |
|
358
Jabil
JBL
$22.5B
| $56.4M | 0.04% |
639,609
-126,668
| -17% | -$11.2M |
|
359
Commercial Metals
CMC
$6.63B
| $55.9M | 0.04% |
1,142,302
-397,939
| -26% | -$19.5M |
|
360
SolarEdge
SEDG
$2.04B
| $55.5M | 0.04% |
182,658
+18,873
| +12% | +$5.73M |
|
361
Cytokinetics
CYTK
$6.34B
| $55.4M | 0.04% |
1,573,644
+1,399,714
| +805% | +$49.3M |
|
362
Ameris Bancorp
ABCB
$5.08B
| $54.8M | 0.04% |
1,497,642
-104,407
| -7% | -$3.82M |
|
363
Amphenol
APH
$135B
| $54.3M | 0.04% |
1,328,018
+16,958
| +1% | +$693K |
|
364
Vanguard FTSE Europe ETF
VGK
$26.9B
| $54M | 0.04% |
885,552
-35,112
| -4% | -$2.14M |
|
365
Valvoline
VVV
$4.96B
| $53.6M | 0.04% |
1,535,001
-265,722
| -15% | -$9.28M |
|
366
Ventyx Biosciences
VTYX
$180M
| $53.5M | 0.04% |
1,598,416
+134,644
| +9% | +$4.51M |
|
367
Trip.com Group
TCOM
$47.6B
| $52.8M | 0.03% |
1,400,200
+1,160,300
| +484% | +$43.7M |
|
368
Tandem Diabetes Care
TNDM
$850M
| $52.6M | 0.03% |
1,294,244
+828,534
| +178% | +$33.6M |
|
369
SBA Communications
SBAC
$21.2B
| $52.5M | 0.03% |
201,284
+184,555
| +1,103% | +$48.2M |
|
|
AZPN
370
DELISTED
Aspen Technology Inc
AZPN
| $52.1M | 0.03% |
227,470
-8
| -0% | -$1.83K |
|
371
LiveRamp
RAMP
$1.86B
| $51.8M | 0.03% |
2,361,680
+16,312
| +0.7% | +$358K |
|
372
Schlumberger
SLB
$53.4B
| $51.2M | 0.03% |
1,042,929
+725,694
| +229% | +$35.6M |
|
373
Selective Insurance
SIGI
$4.86B
| $50.7M | 0.03% |
531,397
-518,473
| -49% | -$49.4M |
|
374
Travelers Companies
TRV
$62B
| $50.6M | 0.03% |
295,301
-9,250
| -3% | -$1.59M |
|
375
Warner Music
WMG
$17B
| $50.6M | 0.03% |
1,516,165
-342,935
| -18% | -$11.4M |
|